common side effects of sandimmune
hirsutism
hypertension
increased blood urea nitrogen
serum creatinine
nephrotoxicity
tremor
comprehensive list of adverse effects
needed effects
cyclosporine
active ingredient
sandimmune
unwanted side effects
medical attention
cyclosporine side effects
medical attention
body
medicine
side effects
health care professional
side effects
following side effects
bk virus
associated nephropathy
serious outcomes
including
deteriorating renal function
renal graft loss
elevations in serum creatinine
bun
cyclosporine
active ingredient
sandimmune
therapy
allograft rejection
addition
cyclosporine-induced hyperuricemia
patient
renal calculi
renal insufficiency
hypertension
cyclosporine
reversible reduction in renal blood flow
glomerular filtration rate
mechanism of cyclosporine-induced nephrotoxicity
vasoconstriction of the afferent arterioles
et
key substance of cyclosporine-induced nephrotoxicity
mild nephrotoxicity
reductions in cyclosporine doses
progressive nephrotoxicity
discontinuation of cyclosporine
renal insufficiency
renal biopsies from these patients
interstitial fibrosis
tubular atrophy
segmental glomerulosclerosis
vascular muscle damage
higher cumulative doses
high cyclosporine trough levels
development of interstitial fibrosis
renal function
differentiation between cyclosporine-induced nephrotoxicity
allograft rejection
other causes of impaired renal function
considering cyclosporine dosage adjustments
use of nonsteroidal anti-inflammatory agents in combination with cyclosporine
risk of renal toxicity
rheumatoid arthritis patients
intact renal prostaglandins
maintaining
maintaining adequate renal blood flow in patients
cyclosporine
renal deterioration
changes in cyclosporine levels
renal side effects
renal insufficiency
bk virus
associated nephropathy
irreversible nephrotoxicity
elevations in serum creatinine
bun
cyclosporine therapy
allograft rejection
case of hemolytic uremic syndrome
hus
cyclosporine therapy
fatal case of acute tubular necrosis
addition
cyclosporine-induced hyperuricemia
patient
renal calculi
seizures in patients on cyclosporine
active ingredient
sandimmune
therapy
hypomagnesemia
concomitant high-dose corticosteroids
addition
hypercholesterolemia
hypertension
cyclosporine neurotoxicity
hypomagnesemia
hypercholesterolemia
easier diffusion of cyclosporine across the blood-brain barrier
potentiating neurotoxicity
review of cyclosporine-induced neurotoxicity
incidence after liver transplantation
intravenous administration of cyclosporine
severe reactions
psychosis
severe reactions
mri abnormalities
patients that experienced neurotoxicity
n =-rrb-
cyclosporine trough levels
toxicity
temporary discontinuation
lowering
dose of cyclosporine
neurotoxicity
patients
tacrolimus therapy without return of neurotoxicity
patient
abnormal magnesium levels
speech disorder
mutism
cyclosporine therapy
symptoms
weeks after withdrawal of the cyclosporine
permanent blindness
patient
neurotoxicity
elevated cyclosporine levels
dechallenge with cyclosporine
blindness
blindness
hour period weeks
kidney-pancreas transplant
cyclosporine trough level
day of complete blindness
ng/ml
mechanism by which cyclosporine
neurologic blindness
nervous system
side effects of cyclosporine
tremors
headache
depression
somnolence
visual acuity
confusion
paresthesias
seizures
reversible speech disorder
mutism
cyclosporine therapy
cases of leukoencephalopathy
postmarketing reports of migraine headache
dermatologic side effects of cyclosporine
active ingredient
sandimmune
hypertrichosis
acne
pruritus
cyclosporine
pilosebaceous lesions
including hypertrichosis
epidermal cysts
keratosis pilaris
acne
folliculitis
sebaceous gland hyperplasia
cutaneous malignancies
case of erythroderma
resembling sezary syndrome with lymphocytic infiltrates of the skin
cases of folliculodystrophy
pseudoporphyria
postmarketing cases of transformation
erythrodermic psoriasis
generalized pustular psoriasis
withdrawal
reduction of cyclosporine in patients with chronic plaque psoriasis
hepatic side effects
occurring
patients
elevated bilirubin
serum transaminases
alkaline phosphatase values
addition
cholestatic jaundice
postmarketing reports of cholestasis
jaundice
hepatitis
liver failure with serious
fatal outcomes
hematologic side effects
leukopenia
anemia
thrombocytopenia
syndrome
thrombocytopenia
microangiopathic anemia
patients
allograft rejection
metabolic side effects of cyclosporine
active ingredient
sandimmune
significant hyperkalemia
hyperchloremic metabolic acidosis
gastrointestinal side effects
gum hyperplasia
diarrhea
nausea
vomiting
anorexia
abdominal discomfort
rare reports of upper gastrointestinal bleeding
pancreatitis
incidence of gum hyperplasia
microemulsion form of cyclosporine
day course of metronidazole mg
times
day
remitting gum hyperplasia in patients with rheumatoid arthritis
increase in serum cyclosporine levels
creatinine levels
metronidazole therapy
effect of metronidazole on gum hyperplasia
antibacterial activity
data
lacking
study
stimulated nitrous oxide production in cyclosporine-treated renal transplant recipients
authors
endothelial dysfunction
increased risk of premature atherosclerosis
cardiovascular death
part
potential mechanism
cyclosporine-induced hypertension
cardiovascular
side effects
hypertension
cyclosporine
myocardial infarction
endocrine side effects of cyclosporine
active ingredient
sandimmune
hypertriglyceridemia
serum prolactin
serum testosterone
gynecomastia
hyperglycemia
hypertrichosis
cremophor el
polyoxyethylated castor oil
vehicle for the intravenous form of cyclosporine
hyperlipidemia
electrophoretic abnormalities of lipoproteins
effects
cessation of therapy
drug withdrawal
other side effects
significant risk of acute rejection
death
graft loss
study
living
living related renal transplant recipients
cyclosporine
active ingredient
sandimmune
average
half months after transplantation
economic constraints
case of trichomegaly
case of calcineurin inhibitor
pain syndrome
cips
anaphylaxis
acute dyspnea
tachypnea
pruritus
rash
chest discomfort
rare cases after intravenous administration of cyclosporine
active ingredient
sandimmune
vehicle
cremophor el
inducing anaphylaxis as some patients
anaphylaxis
administration
oral dosage forms
intravenous cyclosporine
patients
oral medications
route
continuous observation
first minutes of the infusion
hypersensitivity side effects
cyclosporine
patients
rare manifestation of neurotoxicity
cyclosporine
active ingredient
sandimmune
transplant patients
other indications
optic disc edema
papilledema
possible visual impairment
benign intracranial hypertension
ocular side effects
reports of pseudotumor cerebri
discontinuation of cyclosporine
optic disk edema
permanent blindness
patient
case of cyclosporine-induced retinal toxic blindness
development of neoplasms
lymphomas
skin malignancies
immunosuppressed patients
neoplasms
underlying disease
immunosuppressed state
cyclosporine
active ingredient
sandimmune
large study
increased incidence of lymphoma
kaposi
sarcoma
patients
cyclosporine
combination of azathioprine
prednisone
reported cases of b-cell lymphoma
epstein-barr virus genome
malignant cells
suggesting
suggesting opportunistic infection during a cyclosporine-induced immunosuppressed state
oncologic side effects
fatal case of metastatic angiosarcoma during cyclosporine
prednisone immunosuppression
kidney transplantation
immunologic side effects
increased patient susceptibility
opportunistic infections
cyclosporine-induced immunosuppression
postmarketing reports of progressive multifocal leukoencephalopathy
pml
polyoma virus
associated nephropathy
pvan
bk virus
graft loss
accelerated hepatitis b
c infections
resulting in hepatic necrosis
pneumocystis
infections
bacterial infections
patients
cyclosporine
study
enhanced intracellular cytomegalovirus production
virus spread
indicating
increased risk of cmv infection in cyclosporine-treated patients
local side effects
case of recurrent infusion phlebitis
death
part
anaphylactic reaction
reaction
cremophor el
polyoxyethylated castor oil
vehicle for the intravenous formulation
respiratory side effects
respiratory arrest
aspiration pneumonia
patient
death of that patient
side effects of sandimmune
fda
healthcare professional for medical advice
intravenous solution
stomach pain
tenderness
back pain
black, tarry stools
blurred vision
chest pain
chills
clay colored stools
cloudy urine
cough
dark urine
decrease in urine output
urine-concentrating ability
decreased appetite
dizziness
drowsiness
fever
headache
headache
itching
loss of appetite
muscle spasms
tetany
twitching
nausea and vomiting
nervousness
difficult urination
pounding in the ears
shakiness in the legs
arms
hands
feet
shortness of breath
skin rash
fast heartbeat
sore throat
sores
ulcers
white spots on the lips
mouth
swelling of the feet
lower legs
swollen glands
trembling
shaking of the hands
feet
unusual bleeding
bruising
unusual tiredness
weakness
yellow eyes
skin
bleeding gums
blood in the urine
blood in the vomit
burning
crawling
itching
numbness
prickling
pins
needles
tingling feelings
convulsions
difficulty swallowing
hives
pale skin
red spots on the skin
puffiness
swelling of the eyelids
eyes
face
lips
tongue
continuing stomach pain
tightness in the chest
troubled breathing with exertion
bloating
chest discomfort
constipation
darkened urine
hoarseness
indigestion
side pain
night sweats
pain
discomfort in the arms
jaw
neck
pains in the stomach
side
abdomen
radiating
back
sweating
vomiting of blood
material
coffee grounds
stomach discomfort
bleeding
tender
enlarged gums
blemishes on the skin
increased hair growth
face
pain
tenderness around the eyes
cheekbones
pimples
runny nose
brittle fingernails
burning feeling in the chest
stomach
burning
itching eyes
continuing ringing
buzzing
other unexplained noise in the ears
cramps
discharge
excessive tearing
feeling of warmth
hearing loss
redness of the face
neck
arms
upper chest
redness
pain
swelling of the eye
eyelid
inner lining of the eyelid
swelling of the breasts
breast soreness
females
males
weight loss
loss of vision
discouragement
disturbed color perception
double vision
fear
feeling
halos around lights
irritability
joint pain
loss of interest
pleasure
night blindness
overbright appearance of lights
tiredness
trouble concentrating
trouble sleeping
tunnel vision
unusual drowsiness
dullness
tiredness
weakness
feeling of sluggishness
weakness
weight loss